# Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics

Study · id `cardio:ct-nct04183257` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04183257](<https://clinicaltrials.gov/study/NCT04183257>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04183257

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.

## Technical summary

Registry record NCT04183257. Randomized; no masking; primary purpose treatment. Start 2016-09-30 (actual); primary completion 2017-04-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 106 participants (enrolled count; ClinicalTrials.gov record NCT04183257, source copy `cardio:ctgov-nct04183257-2019-12-03`, retrieved 2026-10-26)
- Started: 2016-09-30 (actual) (ClinicalTrials.gov record NCT04183257, source copy `cardio:ctgov-nct04183257-2019-12-03`, retrieved 2026-10-26)
- Primary completion: 2017-04-30 (actual) (ClinicalTrials.gov record NCT04183257, source copy `cardio:ctgov-nct04183257-2019-12-03`, retrieved 2026-10-26)
- Completion: 2017-07-30 (actual) (ClinicalTrials.gov record NCT04183257, source copy `cardio:ctgov-nct04183257-2019-12-03`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04183257-2019-12-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics
- Condition: Vitamin D Deficiency
- Condition: Insulin Resistance
- Condition: Diabetes Mellitus, Type 2
- Intervention (Drug): oral vitamin D
- Lead sponsor: King Edward Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: King Edward Medical University (`cardio:org-king-edward-medical-university`)

## Provenance

Content hash: a04feaddc3eed653f9c7335dc45a3f6592410856289c87ca0434dc2ab60f2331
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
